PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Jul-2021 Scipher Medicine Increases Patient Access for PrismRA® by Expanding Intended Use in Autoimmune Patients B3C newswire
29-Jul-2021 Invitation: Straumann Group 2021 half-year financial results webcast Straumann Holding AG
29-Jul-2021 SIGA announces collaboration with Oxford University to support expanded access protocol for use of TPOXX® (Tecovirimat) to treat monkeypox in Central African Republic SIGA Technologies, Inc.
29-Jul-2021 Macomics, the Macrophage-based Drug Discovery company, secures £4.24m expansion financing, and appoints CEO, CSO and VP Immunology Macomics Ltd
29-Jul-2021 Sanofi appoints new leaders to Executive Committee and announces future Chair of EUROAPI Sanofi
29-Jul-2021 Birmingham cancer project enters Immuno-oncology Alliance Institute of Immunology and Immunotherapy
29-Jul-2021 NRG Therapeutics Awarded $500K Grant from The Michael J. Fox Foundation to Progress Parkinson’s Programme NRG Therapeutics
29-Jul-2021 Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases Cell and Gene Therapy Catapult
29-Jul-2021 4D pharma announces USD 30 million credit facility with Oxford Finance 4D pharma
29-Jul-2021 Dupixent® (dupilumab) significantly improved itch and hives in patients with chronic spontaneous urticaria, a step forward in demonstrating the role of type 2 inflammation in these patients Sanofi
29-Jul-2021 atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs atai Life Sciences
29-Jul-2021 Complix Signs Global Drug Discovery and Development Agreement with Jiangsu Nhwa Pharmaceutical Co. to Develop Novel Alphabody Therapeutics for Treatment of CNS Diseases Complix
29-Jul-2021 STADA and Sanofi strike consumer healthcare distribution agreement in selected countries in Europe STADA and Sanofi
29-Jul-2021 LISTED FOR 20TH CONSECUTIVE YEAR IN FTSE4GOOD INDEX SERIES, AN INDEX FOR SOCIALLY RESPONSIBLE INVESTMENT EISAI
29-Jul-2021 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1) Takeda
29-Jul-2021 Sanofi appoints new leaders to Executive Committee and announces future Chair of EUROAPI Sanofi
29-Jul-2021 SYNLAB: SYNLAB and AXA Partners enter a partnership to enhance safe travel this summer SYNLAB AG
29-Jul-2021 Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round Topas Therapeutics GmbH
29-Jul-2021 Cassiopea Announces Results for First Half of 2021 Cassiopea S.p.A.
28-Jul-2021 MorphoSys AG Reports Second Quarter and First Half 2021 Results MorphoSys AG